Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study
ANNÉE
2018
AUTEURS
Phelip JM, Edeline J, Blanc JF, Barbier E, Michel P, Bourgeois V, Neuzillet C, Malka D, Manfredi S, Desrame J
CONGRÈS/REVUE
Dig Liver Dis
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES